Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery
Spinal Vascular Disorder Nos, Overactive Bladder
About this trial
This is an interventional treatment trial for Spinal Vascular Disorder Nos focused on measuring Spinal Vascular Disorder, Overactive Bladder
Eligibility Criteria
Inclusion Criteria:
•Patient diagnosed with spinal vascular diseases including Intradural arteriovenous malformation,Intradural arteriovenous fistula,Dural arteriovenous fistula,Extradural arteriovenous malformation,Paravertebral arteriovenous malformation,Paravertebral arteriovenous fistula,cobbs' syndrome,and other spinal arteriovenous metameric syndromes involve the spinal cord.
- patient not received surgical or interventional treatment before
- patient with normal cardiac, renal and hepatic function
- patient capable of understanding the content of the patient information / Informed Consent Form
- patient willing and able to participate in the registry
- patients have consistent OAB after surgery
Exclusion Criteria:
•patient received surgical treatment or interventional treatment before
- patient is pregnant
- patient allergic to iodine
- patient unable to complete follow-up
- patient with cerebral lesions
- patient with other spinal lesions
- patient with cardiac, renal or hepatic dysfunction
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
patients with SVMs undergoing SNM
patients with SVMs receiving BTXA
patients with SVMs receiving drug
patients with SVMs are of consistent OAB (Overactive Bladder) after surgery and undergo sacral neuromodulation (SNM)
patients with SVMs are of consistent OAB after surgery and accept botulinum toxin A (BTXA) injection
patients with SVMs are of consistent OAB (Overactive Bladder) after surgery and accept M receptor antagonist